Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001183740-23-000039
Filing Date
2023-03-02
Accepted
2023-03-02 14:37:25
Documents
10
Period of Report
2023-03-01

Document Format Files

Seq Description Document Type Size
1 f6k-20230301drug.htm 6-K 6680
2 NOTICE OF MEETING AND RECORD DATE ex991-nmrd.htm EX-99.1 8010
3 ex991nmrd_1.jpg GRAPHIC 1974
4 NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MARCH 24, 2023 AN ex992-circular.htm EX-99.2 264864
5 ex992circular_1.jpg GRAPHIC 32237
6 PROXY CARD RELATING TO ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MARC ex993-proxy.htm EX-99.3 1107
7 ex993proxy_1.jpg GRAPHIC 153118
8 ex993proxy_2.jpg GRAPHIC 132928
9 FINANCIAL STATEMENT REQUEST FORM ex994-nicard.htm EX-99.4 665
10 ex994nicard_1.jpg GRAPHIC 155575
  Complete submission text file 0001183740-23-000039.txt   938063
Mailing Address 19 VESTRY STREET NEW YORK NY 10013
Business Address 19 VESTRY STREET NEW YORK NY 10013 6474072515
BRIGHT MINDS BIOSCIENCES INC. (Filer) CIK: 0001827401 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40997 | Film No.: 23698144
SIC: 2834 Pharmaceutical Preparations